LTR PHARMA LIMITED - Announcements

24.7%

58.0¢

Market Cap $64.93M

Healthcare Biotechnology

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is developing and commercializing therapies that address significant unmet medical needs. The Company is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The Company is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The Company's subsidiary is LTR Pharma Inc.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

LTP	FY25 Results Announcement	PRICE SENSITIVE	29/08/25	156.91KB	Share
LTP	Appendix 4E and Annual Report to Shareholders	PRICE SENSITIVE	29/08/25	8.64MB	Share
LTP	SPONTAN Case Series - Strong Post-Prostatectomy Results	PRICE SENSITIVE	25/08/25	146.1KB	Share
LTP	18-Month Shelf Life Strengthens SPONTAN Commercialisation	PRICE SENSITIVE	22/08/25	146.52KB	Share
LTP	SPONTAN 5x Faster Onset Validated in EU Journal	PRICE SENSITIVE	20/08/25	153.49KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	323.89KB	Share
LTP	LTP Completes Extractables Study Milestone for SPONTAN	PRICE SENSITIVE	30/06/25	150.21KB	Share
LTP	Urological Expert Appointed to LTR Scientific Advisory Board	PRICE SENSITIVE	21/05/25	124.11KB	Share
LTP	SPONTAN Expands Patient Access via National Pharmacy Network	PRICE SENSITIVE	20/05/25	122.18KB	Share
LTP	LTR Signs Collaborative Agreement to Develop OMD Nasal Spray	PRICE SENSITIVE	08/05/25	157.97KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/25	357.78KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	27/03/25	2.41MB	Share
LTP	Commercial Update and Regulatory Progress	PRICE SENSITIVE	26/03/25	143.08KB	Share
LTP	LTR Pharma to Showcase SPONTAN Data at Urology Conference	PRICE SENSITIVE	28/02/25	144.22KB	Share
LTP	Appendix 4D and Half Yearly Report	PRICE SENSITIVE	27/02/25	14.02MB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	366.1KB	Share
LTP	LTR Signs Symbion National Pharmacy Distribution Agreement	PRICE SENSITIVE	22/01/25	145.13KB	Share
LTP	Response to ASX Query Letters	PRICE SENSITIVE	30/12/24	1.52MB	Share
LTP	Agreement with Men's Health Pharmacy for SPONTAN access	PRICE SENSITIVE	19/12/24	148.1KB	Share
LTP	Early Launch of Online Mens Health Platform	PRICE SENSITIVE	12/12/24	128.77KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	10/12/24	2.96MB	Share
LTP	LTR Pharma Announces Successful A$25 million Placement	PRICE SENSITIVE	10/12/24	141.72KB	Share
LTP	Trading Halt	PRICE SENSITIVE	06/12/24	524.84KB	Share
LTP	JV with Leading Men's Health Group for Online Platform	PRICE SENSITIVE	12/11/24	146.82KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/10/24	335.55KB	Share
LTP	SPONTAN Final Study Results	PRICE SENSITIVE	14/10/24	148.78KB	Share
LTP	FY24 Results Announcement	PRICE SENSITIVE	30/08/24	126.85KB	Share
LTP	Appendix 4E and Annual Financial Report	PRICE SENSITIVE	30/08/24	2.08MB	Share
LTP	SPONTAN Prescribed to First Patient by Authorised Prescriber	PRICE SENSITIVE	16/08/24	146.22KB	Share
LTP	LTP Secures Global CoDevelopment Agreement with Aptar Pharma	PRICE SENSITIVE	13/08/24	129.33KB	Share
LTP	Mens Health Expert Prescribes SPONTAN	PRICE SENSITIVE	08/08/24	157.72KB	Share
LTP	SPONTAN prescribed to First Patient Under TGA	PRICE SENSITIVE	05/08/24	162.37KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/24	293.5KB	Share
LTP	Investor Presentation	PRICE SENSITIVE	24/07/24	2.56MB	Share
LTP	LTR Pharma completes A$10.5 million placement	PRICE SENSITIVE	24/07/24	136.66KB	Share
LTP	Trading Halt	PRICE SENSITIVE	22/07/24	162.76KB	Share
LTP	Reinstatement to quotation	PRICE SENSITIVE	07/06/24	85.61KB	Share
LTP	SPONTAN achieves positive clinical study results	PRICE SENSITIVE	07/06/24	209.2KB	Share
LTP	Suspension from Quotation	PRICE SENSITIVE	06/06/24	163.11KB	Share
LTP	Trading Halt	PRICE SENSITIVE	04/06/24	194.58KB	Share
LTP	Response to ASX Price Query	PRICE SENSITIVE	22/05/24	235.89KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/24	311.04KB	Share
LTP	Final Patients dosed in SPONTAN pivotal study	PRICE SENSITIVE	25/03/24	133.61KB	Share
LTP	First patients dosed in SPONTAN pivotal study	PRICE SENSITIVE	19/03/24	156.8KB	Share
LTP	Appendix 4D and Half Yearly Report	PRICE SENSITIVE	28/02/24	18.93MB	Share
LTP	Recruitment commences for SPONTAN Clinical Study	PRICE SENSITIVE	19/02/24	140.8KB	Share
LTP	SPONTAN Achieves Key Manufacturing Validation	PRICE SENSITIVE	06/02/24	118.16KB	Share
LTP	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/24	335.25KB	Share
LTP	Response to ASX Query Letter	PRICE SENSITIVE	19/12/23	760.22KB	Share

LTP FY25 Results Announcement
29/08/25	PRICE SENSITIVE	156.91KB	Share
LTP Appendix 4E and Annual Report to Shareholders
29/08/25	PRICE SENSITIVE	8.64MB	Share
LTP SPONTAN Case Series - Strong Post-Prostatectomy Results
25/08/25	PRICE SENSITIVE	146.1KB	Share
LTP 18-Month Shelf Life Strengthens SPONTAN Commercialisation
22/08/25	PRICE SENSITIVE	146.52KB	Share
LTP SPONTAN 5x Faster Onset Validated in EU Journal
20/08/25	PRICE SENSITIVE	153.49KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	323.89KB	Share
LTP LTP Completes Extractables Study Milestone for SPONTAN
30/06/25	PRICE SENSITIVE	150.21KB	Share
LTP Urological Expert Appointed to LTR Scientific Advisory Board
21/05/25	PRICE SENSITIVE	124.11KB	Share
LTP SPONTAN Expands Patient Access via National Pharmacy Network
20/05/25	PRICE SENSITIVE	122.18KB	Share
LTP LTR Signs Collaborative Agreement to Develop OMD Nasal Spray
08/05/25	PRICE SENSITIVE	157.97KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/25	PRICE SENSITIVE	357.78KB	Share
LTP Investor Presentation
27/03/25	PRICE SENSITIVE	2.41MB	Share
LTP Commercial Update and Regulatory Progress
26/03/25	PRICE SENSITIVE	143.08KB	Share
LTP LTR Pharma to Showcase SPONTAN Data at Urology Conference
28/02/25	PRICE SENSITIVE	144.22KB	Share
LTP Appendix 4D and Half Yearly Report
27/02/25	PRICE SENSITIVE	14.02MB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	366.1KB	Share
LTP LTR Signs Symbion National Pharmacy Distribution Agreement
22/01/25	PRICE SENSITIVE	145.13KB	Share
LTP Response to ASX Query Letters
30/12/24	PRICE SENSITIVE	1.52MB	Share
LTP Agreement with Men's Health Pharmacy for SPONTAN access
19/12/24	PRICE SENSITIVE	148.1KB	Share
LTP Early Launch of Online Mens Health Platform
12/12/24	PRICE SENSITIVE	128.77KB	Share
LTP Investor Presentation
10/12/24	PRICE SENSITIVE	2.96MB	Share
LTP LTR Pharma Announces Successful A$25 million Placement
10/12/24	PRICE SENSITIVE	141.72KB	Share
LTP Trading Halt
06/12/24	PRICE SENSITIVE	524.84KB	Share
LTP JV with Leading Men's Health Group for Online Platform
12/11/24	PRICE SENSITIVE	146.82KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
28/10/24	PRICE SENSITIVE	335.55KB	Share
LTP SPONTAN Final Study Results
14/10/24	PRICE SENSITIVE	148.78KB	Share
LTP FY24 Results Announcement
30/08/24	PRICE SENSITIVE	126.85KB	Share
LTP Appendix 4E and Annual Financial Report
30/08/24	PRICE SENSITIVE	2.08MB	Share
LTP SPONTAN Prescribed to First Patient by Authorised Prescriber
16/08/24	PRICE SENSITIVE	146.22KB	Share
LTP LTP Secures Global CoDevelopment Agreement with Aptar Pharma
13/08/24	PRICE SENSITIVE	129.33KB	Share
LTP Mens Health Expert Prescribes SPONTAN
08/08/24	PRICE SENSITIVE	157.72KB	Share
LTP SPONTAN prescribed to First Patient Under TGA
05/08/24	PRICE SENSITIVE	162.37KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/07/24	PRICE SENSITIVE	293.5KB	Share
LTP Investor Presentation
24/07/24	PRICE SENSITIVE	2.56MB	Share
LTP LTR Pharma completes A$10.5 million placement
24/07/24	PRICE SENSITIVE	136.66KB	Share
LTP Trading Halt
22/07/24	PRICE SENSITIVE	162.76KB	Share
LTP Reinstatement to quotation
07/06/24	PRICE SENSITIVE	85.61KB	Share
LTP SPONTAN achieves positive clinical study results
07/06/24	PRICE SENSITIVE	209.2KB	Share
LTP Suspension from Quotation
06/06/24	PRICE SENSITIVE	163.11KB	Share
LTP Trading Halt
04/06/24	PRICE SENSITIVE	194.58KB	Share
LTP Response to ASX Price Query
22/05/24	PRICE SENSITIVE	235.89KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
29/04/24	PRICE SENSITIVE	311.04KB	Share
LTP Final Patients dosed in SPONTAN pivotal study
25/03/24	PRICE SENSITIVE	133.61KB	Share
LTP First patients dosed in SPONTAN pivotal study
19/03/24	PRICE SENSITIVE	156.8KB	Share
LTP Appendix 4D and Half Yearly Report
28/02/24	PRICE SENSITIVE	18.93MB	Share
LTP Recruitment commences for SPONTAN Clinical Study
19/02/24	PRICE SENSITIVE	140.8KB	Share
LTP SPONTAN Achieves Key Manufacturing Validation
06/02/24	PRICE SENSITIVE	118.16KB	Share
LTP Quarterly Activities/Appendix 4C Cash Flow Report
30/01/24	PRICE SENSITIVE	335.25KB	Share
LTP Response to ASX Query Letter
19/12/23	PRICE SENSITIVE	760.22KB	Share

REFRESH

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 58.0¢		Change 0.115(24.7%)		Mkt cap ! $64.93M

Open	High	Low	Value	Volume
47.5¢	58.0¢	47.5¢	$1.630M	3.029M

Buyers (Bids)

No.	Vol.	Price($)
1	27566	58.0¢

Sellers (Offers)

Price($)	Vol.	No.
58.5¢	35000	1

View Market Depth

No.	Vol.	Price($)
1	27566	0.580
1	2500	0.575
1	1200	0.550
1	1028	0.535
1	2000	0.530

Price($)	Vol.	No.
0.585	35000	1
0.590	31921	2
0.600	5900	2
0.605	19997	1
0.610	10000	1

Last trade - 16.10pm 12/09/2025 (20 minute delay)

LTP (ASX) Chart

LTR PHARMA LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories